Medpage Today on MSN3mon
Transitioning From Pediatric to Adult Care for Beta-Thalassemia
Patients with beta-thalassemia major (also known as Cooley's anemia) have a reduction or absence of beta protein in their ...
Hosted on MSN2mon
Managing Non-Transfusion-Dependent Thalassemia Presents Challenges
An essential factor in distinguishing thalassemia phenotypes is transfusion dependence. While beta-thalassemia major requires life-long blood transfusions for survival, non-transfusion-dependent ...
National Academies of Sciences%2c Engineering%2c and Medicine5mon
Strategic Plan and Blueprint for Addressing Thalassemia in the United States
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Nasdaq1mon
Agios Pharmaceuticals Files for Regulatory Approval of Mitapivat for Thalassemia as Phase 3 RISE UP Study for Sickle Cell Disease Completes Enrollment
Agios Pharmaceuticals has filed for regulatory approval of its drug Mitapivat (PYRUKYND) to treat adult patients with both non-transfusion-dependent and transfusion-dependent forms of alpha- or ...
Medindia7y
Medications and Drugs for Treatment of Thalassemia
Discover top medications for 'treating Thalassemia'? This page compiles essential information on generic and brand-name drugs specifically used for Thalassemia treatment.Here, you can explore ...
Deccan Chronicle29d
The Silent Suffering of Thalassemia Patients: A Call to Action
Thalassemia, a genetic blood disorder, affects thousands of people in Telangana and Hyderabad, yet awareness and understanding of the condition remain limited. We spoke to Chandrakant Agarwal ...
University of Bristol1y
Immortalised B-thalassemia and CDA IV erythroid lines
Prof. Jan Frayne’s group in the School of Biochemistry renowned for the creation of the Bristol Erythroid Line – Adult (BEL-A) immortalised cell line have expanded their portfolio and created a suite ...